Safety and efficacy of an all-oral interferon-free regimen of seraprevir, an NS3/4A protease inhibitor and sofosbuvir in patients with chronic hepatitis C virus (HCV) genotype 1: an open-label, multicentre, phase 3 trial

被引：0

作者：

Wen, Xiaoyu ^{[1
]}

Kong, Fei ^{[1
]}

Wen, Xiaofeng ^{[2
]}

Wang, Xiaozhong ^{[3
]}

Lin, Shide ^{[4
]}

Wu, Guicheng ^{[5
]}

Wang, Li ^{[6
]}

Xing, Huichun ^{[7
]}

Yan, Xuebing ^{[8
]}

Zheng, Sujun ^{[9
]}

Ning, Qin ^{[10
]}

Wang, Zheng ^{[11
]}

Zhang, Liaoyun ^{[12
]}

Li, Jianmei ^{[13
]}

Tong, Zhaowei ^{[14
]}

Su, Minghua ^{[15
]}

Tong, Lixin ^{[16
]}

Huang, Chengyu ^{[17
]}

Jia, Ji-Dong ^{[18
]}

Xin, Yongning ^{[19
]}

Zhu, Qingjing ^{[20
]}

Wang, Jing ^{[21
]}

Zhang, Yuexin ^{[22
]}

Li, Guangming ^{[23
]}

Niu, Junqi ^{[1
]}

机构：

[1] First Hosp Jilin Univ, Hepatol, Changchun, Peoples R China

[2] Liuzhou Peoples Hosp, Liuzhou, Peoples R China

[3] Xinjiang Uygur Autonomous Reg Tradit Chinese Med, Tibetan, Peoples R China

[4] Zunyi Med Coll, Affiliated Hosp, Zunyi, Guizhou, Peoples R China

[5] Chongqing Three Gorges Cent Hosp, Chongqing, Peoples R China

[6] Chengdu Publ Clin Hlth & Med Ctr, Chengdu, Peoples R China

[7] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China

[8] Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China

[9] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China

[10] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China

[11] Fifth Hosp Wuxi, Wuxi, Jiangsu, Peoples R China

[12] Shanxi Med Univ, Hosp 1, Jinzhong, Peoples R China

[13] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China

[14] Huzhou City Cent Hosp, Huzhou, Peoples R China

[15] Guangxi Med Univ, Hosp 1, Nanning, Peoples R China

[16] Hebei Med Univ, Hosp 1, Shijiazhuang, Hebei, Peoples R China

[17] Chongqing Publ Clin Hlth & Med Ctr, Chongqing, Peoples R China

[18] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[19] Qingdao City Cent Hosp, Qingdao, Peoples R China

[20] Jinyintan Hosp Wuhan, Wuhan, Peoples R China

[21] Southwest Med Univ, Tradit Chinese Med Hosp, Luzhou, Peoples R China

[22] Xinjiang Med Univ, Hosp 1, Urumqi, Peoples R China

[23] Zhengzhou Sixth Peoples Hosp, Zhengzhou, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU391

引用

页码：S330 / S330

页数：1

共 50 条

[1] All-oral, interferon-free therapies for patients with chronic genotype 1 hepatitis C virus infection
Siederdissen, C. Hoener Zu
Cornberg, M.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (47) : 2411 - 2414
[2] Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C
Moucari, Rami
Forestier, Nicole
Larrey, Dominique
Guyader, Dominique
Couzigou, Patrice
Benhamou, Yves
Voitot, Helene
Vidaud, Michel
Seiwert, Scott
Bradford, Bill
Zeuzem, Stefan
Marcellin, Patrick
GUT, 2010, 59 (12) : 1694 - 1698
[3] Furaprevir HCV NS3/4A protease inhibitor Treatment of chronic hepatitis C virus infection
Ghosh, Prithwish
Nehra, Vandana
Temesgen, Zelalem
DRUGS OF THE FUTURE, 2022, 47 (08) : 557 - 565
[4] Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial
Kong, Fei
Wen, Xiaoyu
Wen, Xiaofeng
Wang, Xiaozhong
Wu, Guicheng
Lin, Shide
Wang, Li
Xing, Huichun
Yan, Xuebing
Zheng, Sujun
Ning, Qin
Wang, Zheng
Zhang, Liaoyun
Lin, Jianmei
Tong, Zhaowei
Huang, Chengyu
Su, Minghua
Tong, Lixin
Jia, Jidong
Xin, Yongning
Zhu, Qingjing
Wang, Jing
Chen, Li
Li, Xiaowen
Wu, Xuegang
Niu, Duan
Liu, Quan
Wei, Wei
Zhang, Yuexin
Li, Guangming
Niu, Junqi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (09) : 2375 - 2382
[5] SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF MK-7009, A NOVEL INHIBITOR OF THE HEPATITIS C VIRUS NS3/4A PROTEASE, IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION
Lawitz, Eric J.
Sulkowski, Mark S.
Jacobson, Ira M.
Faruqui, Shaban
Kraft, Walter K.
Maliakkal, Benedict
Al-Ibrahim, Mohamed
Ghalib, Reem H.
Gordon, Stuart C.
Kwo, Paul
Rockstroh, Juergen
Miller, Michelle
Hwang, Peggy
Gress, Jacqueline
Quirk, Erin
HEPATOLOGY, 2008, 48 (04) : 403A - 404A
[6] Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics
Lawitz, Eric
Sulkowski, Mark
Jacobson, Ira
Kraft, Walter K.
Maliakkal, Benedict
Al-Ibrahim, Mohamed
Gordon, Stuart C.
Kwo, Paul
Rockstroh, Juergen Kurt
Panorchan, Paul
Miller, Michelle
Caro, Luzelena
Barnard, Richard
Hwang, Peggy May
Gress, Jacqueline
Quirk, Erin
Mobashery, Niloufar
ANTIVIRAL RESEARCH, 2013, 99 (03) : 214 - 220
[7] PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC RELATIONSHIP FOR MK-5172, A NOVEL HEPATITIS C VIRUS (HCV) NS3/4A PROTEASE INHIBITOR, IN GENOTYPE 1 AND GENOTYPE 3 HCV-INFECTED PATIENTS
Caro, Luzelena
Anderson, Melanie
Du, Lihong
Palcza, John
Han, Lingling
Van Dyck, Kristien
Robberechts, Martine
De Lepeleire, Inge M.
Petry, Amelia
Young, Mary Beth
Fraser, Iain P.
O'Mara, Edward
Moiseev, Valentine S.
Kobalava, Z. D.
Wagner, Frank D.
HEPATOLOGY, 2011, 54 : 1005A - 1005A
[8] Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naive or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
Gane, Edward J.
Schwabe, Christian
Hyland, Robert H.
Yang, Yin
Svarovskaia, Evguenia
Stamm, Luisa M.
Brainard, Diana M.
McHutchison, John G.
Stedman, Catherine A.
GASTROENTEROLOGY, 2016, 151 (03) : 448 - +
[9] Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection
Manns, Michael P.
Bourliere, Marc
Benhamou, Yves
Pol, Stanislas
Bonacini, Maurizio
Trepo, Christian
Wright, David
Berg, Thomas
Calleja, Jose L.
White, Peter W.
Stern, Jerry O.
Steinmann, Gerhard
Yong, Chan-Loi
Kukolj, George
Scherer, Joe
Boecher, Wulf O.
JOURNAL OF HEPATOLOGY, 2011, 54 (06) : 1114 - 1122
[10] Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy
Vicenti, Ilaria
Rosi, Andrea
Saladini, Francesco
Meini, Genny
Pippi, Francesco
Rossetti, Barbara
Sidella, Letizia
Di Giambenedetto, Simona
Almi, Paolo
De Luca, Andrea
Caudai, Cinzia
Zazzi, Maurizio
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 984 - 987

← 1 2 3 4 5 →